Sponsor:
Thomas Jefferson University
Code:
NCT05627232
Conditions
Recurrent Acute Myeloid Leukemia
Refractory Acute Myeloid Leukemia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Tazemetostat
Liposome-encapsulated Daunorubicin-Cytarabine
Bone Marrow Aspiration and Biopsy
Biospecimen Collection
Palbociclib
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-07-05. This information was provided to ClinicalTrials.gov by Thomas Jefferson University on 2024-01-05.